Classification of daily and near-daily headaches
Field trial of revised IHS criteria
Abstract
Primary chronic daily headache can be subdivided into transformed migraine, chronic tension-type headache, hemicrania continua, and new daily persistent headache. We proposed and tested criteria in 150 consecutive outpatients with chronic daily headache. Based on preliminary analysis, we revised the criteria for transformed migraine. Using the International Headache Society criteria, 43% of the patients could not be classified; using our old criteria, 25% could not be classified; however, using our new criteria, we were able to classify 100%. Seventy-eight percent had transformed migraine, 15.3% had chronic tension-type headache, and 6.7% had other headache disorders.
NEUROLOGY 1996;47: 871-875
Get full access to this article
View all available purchase options and get full access to this article.
REFERENCES
1.
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8(suppl 7):1-96.
2.
Silberstein SD. Chronic daily headache and tension-type headache. Neurology 1993;43:1644-1649.
3.
Saper J. Daily chronic headache. Neurol Clin 1990;8:891-901.
4.
Solomon S, Lipton RB, Newman LC. Evaluation of chronic daily headache: comparison to criteria for chronic tension-type headache. Cephalalgia 1992;12:365-368.
5.
Sanin LC, Mathew NT, Bellmyer LR, Ali S. The International Headache Society (IHS) headache classification as applied to a headache clinic population [abstract]. Headache 1993;33:266.
6.
Messinger HB, Spierings ELH, Vincent AJP. Overlap of migraine and tension-type headache in the International Headache Society classification. Cephalalgia 1991;11:233-237.
7.
Pfaffenrath V, Isler H. Evaluation of the nosology of chronic tension-type headache. Cephalalgia 1993;13(suppl 12):60-62.
8.
Sandrini G, Manzoni GC, Zanferrari C, Nappi G. An epidemiological approach to the nosography of chronic daily headache. Cephalalgia 1993;13(suppl 12):72-77.
9.
Mathew NT. Transformed migraine. Cephalalgia 1993;13(suppl 12):78-83.
10.
Mathew NT, Stubits E, Nigam MR. Transformation of episodic migraine into daily headache: analysis of factors. Headache 1982;22:66-68.
11.
Mathew NT. Chronic daily headache. In: Nappi G, Bono G, Sandrini G, Martignoni E, Micieli G, eds. Headache and depression--serotonin pathways: a common clue. New York: Raven Press, 1991:49-58.
12.
Saper JR. Ergotamine dependency: a review. Headache 1987;27:435-438.
13.
Mathew NT, Kurman R, Perez F. Drug-induced refractory headache: clinical features and management. Headache 1990;30:634-638.
14.
Solomon S, Lipton RB, Newman LC. Clinical features of chronic daily headache. Headache 1992;32:325-329.
15.
Silberstein SD, Lipton RB, Solomon S, Mathew N. Classification of daily and near-daily headaches: proposed revisions to the IHS criteria. Headache 1994;34:1-7.
16.
Saper JR. Headache disorders: current concepts in treatment strategies. Littleton, MA: Wright-PSG Publishers, 1983.
17.
Silberstein SD, Silberstein JR. Chronic daily headache: prognosis following inpatient treatment with repetitive IV DHE. Headache 1992;32:439-445.
18.
Diamond S, Dalessio DJ. Drug abuse in headache. In: The practicing physician's approach to headache. 3rd ed. Baltimore: Williams & Wilkins, 1982:114-121.
19.
Silberstein SD. Appropriate use of abortive medication in headache treatment. Pain Management 1991;4:22-28.
20.
Scholz E, Diener H-C, Geiselhart S. Drug-induced headache: does a critical dosage exist? In: Diener H-C, Wilkinson M, eds. Drug-induced headache. Berlin: Springer-Verlag 1988:29-43.
21.
Wilkinson M. Introduction. In: Diener H, Wilkinson M, eds. Drug-induced headache. Berlin: Springer-Verlag, 1988:1-2.
22.
Manzoni GC, Granella F, Sandrini G, Cavalini A, Zanferrari C, Nappi G. Classification of chronic daily headache by International Headache Society criteria: limits and new proposals. Cephalalgia 1995;15:37-43.
Information & Authors
Information
Published In
Copyright
Copyright 1996 by Advanstar Communications Inc.
Publication History
Published online: October 1, 1996
Published in print: October 1996
Authors
Metrics & Citations
Metrics
Citation information is sourced from Crossref Cited-by service.
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Altered Neuromagnetic Activity in the Default Mode Network in Migraine and Its Subgroups (Episodic Migraine and Chronic Migraine), Journal of Integrative Neuroscience, 23, 1, (2024).https://doi.org/10.31083/j.jin2301019
- High-frequency episodic migraine: Time for its recognition as a migraine subtype?, Cephalalgia, 44, 10, (2024).https://doi.org/10.1177/03331024241291578
- Utility of Repetitive Transcranial Magnetic Stimulation for Chronic Daily Headache Prophylaxis: A Systematic Review and Meta-Analysis, Current Pain and Headache Reports, 28, 4, (149-167), (2024).https://doi.org/10.1007/s11916-024-01210-0
- The first interim analysis of Italian patients enrolled in the real-world, Pan-European, prospective, observational, phase 4 PEARL study of fremanezumab effectiveness, Neurological Sciences, 45, 5, (2353-2363), (2024).https://doi.org/10.1007/s10072-024-07357-3
- Algorithm-based approach to headache, Journal of Family Medicine and Primary Care, 12, 9, (1775-1783), (2023).https://doi.org/10.4103/jfmpc.jfmpc_1553_22
- Response to Mindfulness-Based Cognitive Therapy Differs Between Chronic and Episodic Migraine, Neurology Clinical Practice, 11, 3, (194-205), (2023)./doi/10.1212/CPJ.0000000000000984
- Trial protocol for a multicenter randomized controlled trial to assess the efficacy and safety of intravenous ketamine for chronic daily headaches: the “KetHead” trial, Trials, 24, 1, (2023).https://doi.org/10.1186/s13063-023-07186-3
- Association between iron deficiency anemia and chronic daily headache: A case-control study, Cephalalgia, 43, 2, (2023).https://doi.org/10.1177/03331024221143540
- Treatment of chronic migraine with Botox (onabotulinumtoxinA): Development, insights, and impact, Medicine, 102, S1, (e32600), (2023).https://doi.org/10.1097/MD.0000000000032600
- Chronic migraine and medication overuse, Migraine Biology, Diagnosis, and Co-Morbidities, (187-200), (2023).https://doi.org/10.1016/B978-0-12-823356-6.00008-1
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.
If you need immediate support or to place an order, please call or email customer service:
- 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
- 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
- [email protected]
We appreciate your patience during this time and apologize for any inconvenience.